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Generation of Multiple Bioactive Macrolides
by Hybrid Modular Polyketide Synthases
in Streptomyces venezuelae
additional processing steps. Catalytic domains that per-
form these reactions include a keto reductase (KR), a
dehydratase (DH), and an enoyl reductase (ER). The
absence of any -keto-processing domain results in the
presence of a ketone, a KR alone gives rise to a hydroxyl,
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The pikromycin (Pik) PKS of S. venezuelae has severalThe plasmid-based replacement of the multifunctional
protein subunits of the pikromycin PKS in S. vene- remarkable features that make it a powerful system for
combinatorial biosynthesis. Such features include thezuelae by the corresponding subunits from heterolo-
gous modular PKSs resulted in recombinant strains ability to produce both 12- and 14-membered ring mac-
rolides [9] (Figure 1A). Recent work has shown that alter-that produce both 12- and 14-membered ring macro-
lactones with predicted structural alterations. In all native expression of the Pik PKS results in the genera-
tion of two macrolactone structures [10]. Expression ofcases, novel macrolactones were produced and fur-
ther modified by the DesVII glycosyltransferase and full-length PikAIV (the last module required for heptake-
tide chain elongation) generates the 14-membered ringPikC hydroxylase, leading to biologically active macro-
lide structures. These results demonstrate that hybrid macrolactone narbonolide, whereas expression of an
N-terminally truncated form of PikAIV (with the alterna-PKSs in S. venezuelae can produce a multiplicity of
new macrolactones that are modified further by the tive translation start codon 600 amino acids downstream
of the normal pikAIV start codon) results in skipping ofhighly flexible DesVII glycosyltransferase and PikC hy-
droxylase tailoring enzymes. This work demonstrates the final condensation cycle to generate the 12-mem-
bered ring macrolactone 10-deoxymethynolide. The un-the unique capacity of the S. venezuelae pikromycin
pathway to expand the toolbox of combinatorial bio- usual nature of the S. venezuelae system provides a
potentially useful tool for generating multiple productssynthesis and to accelerate the creation of novel bio-
logically active natural products. from a single hybrid modular PKS by combinatorial bio-
synthesis [11, 12].
Another strength of the S. venezuelae system is theIntroduction
presence of two tailoring enzymes that have unusual
substrate flexibility (they recognize both 12- and 14-Modular polyketide synthases (PKSs) are large multi-
functional enzymes that are responsible for the biosyn- membered ring macrolactones). Specifically, there is
one DesVII glycosyltransferase that can accept both 12-thesis of macrolides and other macrocyclic polyketides
whose members have diverse structural and pharmaco- and 14-membered ring aglycones [13]. PikC (a P450
hydroxylase) also accepts both macrolide substrateslogical properties [1]. These modular PKS assemblies
and is active at two positions on the macrolactone sys-are formed by giant multifunctional enzymes harboring
tem [14]. Because structural modifications are often crit-one to many modules that catalyze serial condensations
ical for biological activity, a current challenge for combi-of activated coenzyme-A thioester monomers derived
natorial biosynthesis is to develop approaches that leadfrom small organic acids such as acetate, propionate,
not only to novel macrolactones but also to ones thatand butyrate [2–4]. Each module contains distinctive
provide fully elaborated structures.active site domains required for one cycle of polyketide
Here, using a set of hybrid modular systems basedelongation. Active sites required for condensation in-
on the Pik, tylosin (Tyl) and erythromycin (DEBS) PKSsclude an acyltransferase (AT), an acyl carrier protein
(Figures 1A, 1B, and 1C), we report novel combinatorial(ACP), and a -ketoacyl synthase (KS). Each condensa-
biosynthetic approaches in S. venezuelae. The threetion cycle results in a -keto group that can undergo
systems were chosen based on biochemical architec-
ture (e.g., the presence of bimodular PikAI, DEBS1, and3 Correspondence: david-s@biosci.umn.edu
TylGI; two final monomodular PKSs in PikAIII/PikAIV and4 Present address: Department of Chemistry, Chungbuk National
University, Cheongju, Chungbuk 361-763, South Korea. TylGIV/TylGV) as well as the structural similarity of their
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Figure 1. Modular Organization and the Products of Pik PKS, Tyl PKS, and Erythromycin PKS
Modular organization and the products of (A) Pik PKS, (B) Tyl PKS, and (C) erythromycin (DEBS) PKS (6-deoxyerythronolide B synthase). Each
protein subunit is shown as a broad arrow, with the domains indicated by symbols explained in the text. Each module catalyzes one
cycle of chain elongation and associated -keto processing for the biosynthesis of corresponding macrolactones. Pik PKS produces 10-
deoxymethynolide (1) and narbonolide (2). Final products are methymycin (3), neomethymycin (4), pikromycin (5), and narbomycin (6). Tyl PKS
generates tylactone (7), which is modified further to tylosin (8). DEBS PKS produces 6-deoxyerythronolide B, which is converted to erythromycin
A, B, C, and D (10, 11, 12, and 13, respectively). Post-polyketide modifications are highlighted in different colors: hydroxylation, pink;
glycosylation, red.
product profiles. These attributes provided a framework involved creation of heterodimeric forms of the multi-
functional protein in which native PikAIV interacted withfrom which to address new questions about molecular
recognition between heterologous monomodular PKSs as a hybrid bearing AT and ACP domains from the Rap PKS
[12]. The results provided new insights into molecularwell as to probe the flexibility of the DesVII glycosyltrans-
ferase and PikC hydroxylase toward novel substrates. recognition of the Pik PKS, but they also demonstrated
that some homodimeric forms of the hybrid PikAIV pro-
teins are unable to produce detectable levels of polyke-Results and Discussion
tide because of inefficient catalysis. Previous work has
shown that protein subunits from heterologous modularIn a recent report, we described an initial investigation of
the mechanisms of molecular recognition in the PikAIV PKSs can be functionally assembled in ways that im-
prove the yield of product formation relative to engi-(module 6) of the Pik PKS. One aspect of this analysis
Production of Multiple Macrolides by Hybrid Modular PKSs
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Figure 2. Organization of the pik Cluster in Wild-Type S. venezuelae and Pik PKS Deletion Mutants
Organization of the pik cluster in (A) wild-type S. venezuelae, (B) pikAIV deletion mutant HK954, (C) pikAIII-pikAIV deletion mutant YJ004, and
(D) pikAI deletion mutant BB138. Each arrow represents an ORF. The direction of transcription and relative sizes of the ORFs are indicated.
aphII and pikAV encode the kanamycin resistance gene [25] and type II thioesterase [13], respectively. After PKS gene deletion, pikAV and
other downstream genes remain intact and can still be expressed.
neered domain replacements [7]. We therefore were mo- tion of both 12- and 14-membered ring macrolides at
levels similar to those of wild-type S. venezuelae.tivated to design a more efficient system for the creation
of hybrid Pik PKSs by subunit replacements in a genetic Upon successful complementation of the S. venezuelae
pikAIV deletion mutant with pDHS4162, we proceededbackground lacking expression of the corresponding
native Pik modules. to test the ability of a related heterologous monomodular
PKS to functionally replace the mutant Pik PKS system.
A plasmid expressing the Tyl PKS module 7 multifunc-Complementation of the S. venezuelae pikAIV
Deletion Mutant by pikAIV and tylGV tional protein (TylGV, [pDHS3007]) was constructed and
transformed into S. venezuelae HK954. Analysis of theTo construct hybrid PKSs in the final module of the Pik
PKS, we generated an S. venezuelae mutant strain (HK954) complementation results provides information on sev-
eral key issues. First, the AT domain in Tyl module 7bearing a deletion of pikAIV (Figure 2B) and performed a
series of complementation experiments. Complementa- is specific for malonyl-CoA extension as opposed to
PikAIV, which specifies chain extension by methylmalo-tion was carried out with a low-copy plasmid of SCP2*
origin (pDHS4162) [10, 11] under control of the native pikAI nyl-CoA. Secondly, Tyl module 7 includes a KR domain
that is absent from Pik module 6. Thus, the 14-mem-promoter. Expression of PikAIV in the HK954/pDHS4162
strain (Figure 3A) restored production of 12- and 14- bered ring macrolactone expected from the resulting
Pik-Tyl hybrid PKS is 2-desmethyl-3-dihydro-narbono-membered ring macrolides to wild-type levels (our un-
published data). This initial experiment demonstrated lide (14). Moreover, the expected macrolides from glyco-
sylation/hydroxylation are 2-desmethyl-3-dihydro-pik-that subunit complementation of plasmid-expressed
PikAIV restores function of the Pik PKS for the produc- romycin (15) and 2-desmethyl-3-dihydro-narbomycin
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Figure 3. Polyketides Produced by Functional Replacement of PikAIV and Partial Sequence Alignment of PikAIV and TylGV
Polyketides produced by complementation of PikAIV with native and hybrid TylGV (B–D) and partial sequence alignment of PikAIV and TylGV.
Alternative ribosome binding sites and start codons are shown in blue and red text, respectively (E). Domains from Pik PKS are marked in
yellow, and those from Tyl PKS (A–D) are in red. Des represents all eight enzymes for desosamine biosynthesis and transfer [13], and PikC
is the cytochrome P450 monooxygenase responsible for hydroxylation [14]. Alternative ribosome binding sites and start codons are shown
in blue and red text, respectively.
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Figure 4. LC/MS and MS/MS Analyses of Aglycones Produced from S. venezuelae Wild-Type and HK954/pDHS3007 Strains
Comparison of LC/MS and MS/MS analyses of aglycones produced from S. venezuelae wild-type (A–D) and HK954/pDHS3007 (E–H) strains.
(A) LC/MS selected for amu  297, corresponding to compound 1 produced from the S. venezuelae wild-type strain.
(B) LC/MS selected for amu  353, corresponding to compound 2 produced from the S. venezuelae wild-type strain.
(C) MS/MS spectrum corresponding to compound 1 produced from S. venezuelae wild-type strain.
(D) MS/MS spectrum corresponding to compound 2 produced from S. venezuelae wild-type strain.
(E) LC/MS selected for amu  297, corresponding to compound 1 produced from HK954/pDHS3007 strain.
(F) LC/MS selected for amu  341, corresponding to compound 14 produced from HK954/pDHS3007 strain.
(G) MS/MS spectrum corresponding to compound 1 produced from HK954/pDHS3007 strain.
(H) MS/MS spectrum corresponding to compound 14 produced from HK954/pDHS3007 strain (see text for a detailed description of the MS/
MS signals).
(16). Clear evidence that the recombinant strain (HK954/ that DesVII can accept a range of novel sugar substrates
generated in vivo by genetic manipulation of the despDHS3007) produces the predicted macrolactone (14)
was obtained by the combination of liquid chromatogra- biosynthetic system in S. venezuelae [15–17]. The cur-
rent study takes this a step further by showing that novelphy/mass spectrometry (LC/MS) and mass/mass spec-
trometry (MS/MS) (Figure 3B). We detected the parent macrolactone substrates generated in vivo through
combinatorial biosynthesis can serve as substrates forion (MH) of the expected compound (14) at 341 amu.
At 323 and 305 amu, we detected two characteristic ions both DesVII and PikC.
Surprisingly, the 12-membered ring macrolactonesfor the corresponding dehydration products, which are
produced by the loss of two hydroxyl groups at C-3 and 10-deoxymethynolide and the corresponding macro-
lides, methymycin and neomethymycin, were detectedC-5 of the new hybrid aglycone (14) under the ionization
conditions used (Figure 4). Moreover, LC/MS and MS/ from culture extracts of the HK954/pDHS3007 recombi-
nant strain (Figures 3B and 4). The unique ability of theMS demonstrated production of the predicted macrolide
antibiotics. The parent ions (514 amu and 498 amu, re- Pik PKS of S. venezuelae to produce both 12- and 14-
membered ring macrolactones was shown previouslyspectively) of the new macolides 15 and 16 were de-
tected along with the characteristic desosamine moiety to involve an N-terminally truncated form of PikAIV that
is unable to catalyze the final chain elongation step [10].ion (158 amu) as well as patterns of the corresponding
dehydration products. Thus, the hybrid 14-membered Nucleotide sequence alignment of the 5 regions of pikAIV
and tylGV indicated a high degree of homology. However,ring aglycone (14) was elaborated further by DesVII (gly-
cosyltransferase) and PikC (P450 hydroxylase) to form a minor difference was identified in the predicted ribosome
binding site and in one of two possible start codons (Figurenovel glycosylated and hydroxylated compounds (struc-
tures 15 and 16, Figure 3B). Previous work has shown 3E). A recent report suggested that Streptomyces narbo-
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Figure 5. Polyketides Produced by Functional Replacement of PikAI
Domains from Pik PKS are marked in yellow, and those from Tyl PKS are in red. Des represents all eight enzymes for desosamine biosynthesis
and transfer [13], and PikC is the cytochrome P450 monooxygenase responsible for hydroxylation [14].
nensis, which produces only 14-membered ring macro- not shown). This result demonstrates that metabolic en-
gineering of the host strain can improve production lev-lides, is unable to generate a truncated form of PikAIVnrb,
compared to PikAIV, due to a nucleotide sequence varia- els of hybrid biosynthetic systems in S. venezuelae and
ease the challenge of product identification.tion in the downstream ribosome binding site [9]. It re-
mains unclear whether differential expression of TylGV
is the basis for production of 10-deoxymethynolide in Complementation of the S. venezuelae pikAIV
Deletion Mutant by a tylGV::pikAIVthis hybrid system, or whether other mechanism(s) en-
able these hybrid PKSs to produce two different macrolac- Hybrid Module
Previous work in the DEBS system has shown that pro-tones [18]. However, these results demonstrate clearly
that hybrid PKSs involving Tyl module 7 in S. venezuelae ductive transfer of a polyketide chain elongation inter-
mediate in a modular PKS is facilitated by preservingare capable of producing two macrolactone ring sys-
tems from a single hybrid PKS. the native intermolecular contacts between an ACP and
the following KS domain [21]. The production levels ofOne of the key challenges of combinatorial biosynthe-
sis involving modular PKSs is the significantly reduced macrolides in the HK954/pDHS3007 strain was lower
as compared to wild-type S. venezuelae. We thereforeproductivity of the hybrid systems [7, 19]. The yield of
new macrolides produced from the hybrid PKSs in sought to increase the production efficiency by main-
taining the native interaction between an ACP and itsS. venezuelae (see below) requires sensitive analytical
methods such as LC/MS for detection. Moreover, the cognate KS domain. We also wished to investigate the
effect of native KS and AT domains in Pik module 6yields of all the new compounds in this study (see below)
were approximately one hundred-fold less (approxi- on production of 12-membered ring macrolides and to
access novel structures. Two plasmids were con-mately 50–100 g/liter) than typical S. venezuelae wild-
type production levels, which complicates the quantita- structed and introduced into HK954 for expression of
hybrid PikAIV modules. One comprises the KS domaintive comparisons between mutant strains based on LC/
MS analysis. of PikAIV and the AT-KR-ACP-TE domains from TylGV
(PikAIV KS6-[AT7-KR7-ACP7-TE]TylGV), and the other com-To enhance productivity of the HK954/pDHS3007
strain, we cloned the PikD transcriptional activator [13, prises the KS-AT domains of PikAIV and the KR-ACP-
TE domains from TylGV, respectively (PikAIV KS6-AT6-20] in a second compatible vector (which compared to
pDHS3007 has the same origin of replication and pikAI [KR7-ACP7-TE]TylGV).
Transformation of the pikAIV-deleted HK954 strain bypromoter, but a unique resistance marker) and trans-
formed it into S. venezuelae HK954/pDHS3007. LC/MS pDHS3016 expressing PikAIV KS6-[AT7-KR7-ACP7-TE]TylGV
resulted in a strain (HK954/pDHS3016) capable of pro-analysis revealed that the resulting recombinant strain
provided a greater-than-2-fold increase in the produc- ducing the same hybrid macrolides as S. venezuelae
HK954/pDHS3007 (Figure 3C). The amount of both 12-tion of both 12- and 14-membered ring macrolides (data
Production of Multiple Macrolides by Hybrid Modular PKSs
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Figure 6. Polyketides Produced by Functional Replacement of PikAI
Domains from Pik PKS are marked in yellow, those from Tyl PKS are in red, and those from DEBS PKS are in blue. Des represents all eight
enzymes for desosamine biosynthesis and transfer [13], and PikC is the cytochrome P450 monooxygenase responsible for hydroxylation [14].
and 14-membered ring macrolides produced from HK954/ MS (Figure 3D). The parent ions (355, 528, and 512 amu,
respectively) of the new macrolactone 17, and macro-pDHS3016 was similar to levels produced when the com-
plete TylGV module was used (HK954/pDHS3007). Com- lides 18 and 19 were detected along with the character-
istic patterns of the corresponding dehydration prod-pared to expression in HK954/pDHS3007 and HK954/
pDHS3016, plasmid-based (pDHS3023) expression of the ucts, as well as the desosamine moiety ion (158 amu)
for the macrolide compounds. These results indicatePikAIV KS6-AT6-[KR7-ACP7-TE]TylGV hybrid polypeptide
comprising KS and AT domains of PikAIV and KR-ACP- that simply preserving the native Pik ACP5/KS6 domains
in a hybrid Pik-Tyl PKS construct is not sufficient toTE domains from TylGV in the HK954 strain also pro-
duced equivalent levels of 14-membered ring macrolac- restore molecular recognition for efficient polyketide as-
sembly.tones, 3-dihydro-narbonolide (17), 3-dihydro-pikromycin
(18), and 3-dihydro-narbomycin (19), and 12-membered Interestingly, introduction of engineered restriction
sites used for domain fusion does not adversely affectring macrolactones as determined by LC/MS and MS/
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Complementation of the S. venezuelae pikAIII-
pikAIV Deletion Mutant by tylGIV-tylGV
It is conceivable that the native genetic architecture of
pikAIII-pikAIV plays a significant role in the regulation
of macrolactone ring size formation in S. venezuelae.
Specifically, transcriptional and/or translational control
of domain skipping may occur through cis-related ele-
ments (e.g., unique transcriptional start point) inherent
to pikAIII-pikAIV on the S. venezuelae chromosome
rather than by trans-activated mechanisms. To address
this question and to extend the investigation of generat-
ing hybrid PKS systems, we deleted the pikAIII and
pikAIV genes from the S. venezuelae (YJ004) chromo-
some by exchanging them with aphII (Figure 2C). This
was followed by functional replacement using plasmids
expressing TylGIV-TylGV and hybrid TylGIV-TylGV mod-
ules containing the ACP domain of PikAIII and KS-AT
domains from PikAIV (Figures 5B and 5C). Plasmid-
based (pDHS4111) expression of PikAIII and PikAIV in
the YJ004 strain (Figure 5A) restored antibiotic produc-
tion to wild-type levels (data not shown), demonstrating
that complementation of two protein subunits from a plas-
mid in S. venezuelae generates a fully functional PKS.
Transformation of the YJ004 strain by the pDHS3003
expressing a complete TylGIV and TylGV generated a
strain (YJ004/pDHS3003) that produces the same 12-
and 14-membered ring macrolides as HK954/pDHS3007
and HK954/pDHS3016 strains at the same levels (Figure
5B). Because the catalytic domain organization of TylGIV
and PikAIII is identical (e.g., KS-AT-KR-ACP), the pre-
dicted structure of the 14-membered ring macrolides
produced by YJ004/pDHS3003 strain is the same as the
structure of those produced by HK954/pDHS3007.
A plasmid (pDHS3031) expressing the hybrid poly-
peptide TylGIV KS6-AT6-KR6-[ACP5]PikAIII–PikAIV KS6-AT6-Figure 7. Biological Activity of Fractionated Organic Solvent Ex-
[KR7-ACP7-TE]TylGV was constructed and introduced intotracts from Strains Containing Hybrid PKSs
the YJ004 strain. The resulting recombinant (YJ004/The text below each TLC spot indicates the strain name from which
pDHS3031) generated the same 12- and 14-memberedthe extract was prepared. The multiple zones of growth inhibition
demonstrate the generation of multiple macrolides by a single engi- ring macrolides, at approximately the same production
neered biosynthetic pathway. levels as HK954/pDHS3023 (Figure 5C).
Production of 12-membered ring macrolides from the
YJ004/pDHS3003 and YJ004/pDHS3031 strains sug-
production levels of the native macrolactone systems. gests that domain skipping occurs with similar efficiency
The HindIII restriction site introduced in pDHS3016 (Fig- from TylGV or the PikAIV-TylGV (pDHS3031) hybrid mod-
ure 3C), located at the inter-domain linker between KS7- ule. Thus, the requirement for a native PikAIII and PikAIV
AT7 domains in TylGV altered one amino acid residue interaction is not a necessary condition for alternative
(Ala449 to Ser). Successful fusions between DEBS mod- expression of PikIV (module 6). It is also worthy of note
ules using this junction have been described previously that the engineered EcoRI restriction site located at the
[21]. Moreover, when the same amino acid change was intermodular linker between KR6-ACP6 domains in
introduced into the protein product of pDHS3007 and TylGIV (resulting in an Ala1385-to-Gly amino acid
transformed in to HK954 strain, the level of antibiotic change in TylGIV; tested in pDHS3003) as mentioned
production of the resulting mutant was indistinguishable above has no effect on the phenotype of the mutant
from that of the HK954/pDHS3007 strain, indicating that (Figure 5C).
this engineered fusion site has no adverse effect on PKS These results demonstrate that S. venezuelae is par-
function or molecular recognition. The PstI restriction ticularly amenable as a host for combinatorial biosynthe-
site introduced in pDHS3023 (Figure 3D), located at the sis. First, the hybrid PKSs generated by subunit comple-
inter-domain linker between AT-ACP domains in TylGV mentation produce multiple macrolides when native or
also changed one amino acid residue (Ala935 to Gln). heterologous KS domains are used. It is possible that
As reported previously for fusions of DEBS modules the heterologous subunits (TylGIV and TylGV) used in
using an identical engineered junction site [19, 22], there this study have an exceptionally high evolutionary rela-
was no change in the level of macrolides produced when tionship with the Pik PKS and thus share the mechanism
the Ala935Gln alteration was introduced into the product for production of two macrolactone ring systems. Interest-
ingly, constraints on ring cyclization due to the doubleof pDHS3007.
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Table 1. Strains and Plasmids Used for PKS Expression
Strain/Plasmid Description Reference
Strain
S. venezuelae Wild-type
ATCC 15439
S. venezuelae pikAIV deletion mutant This study
HK954
S. venezuelae pikAIII-pikAIV deletion mutant This study
YJ004
S. venezuelae pikAI deletion mutant This study
BB138
Plasmid
pDHS618 E. coli-Streptomyces shuttle plasmid vector [11]
pDHS702 E. coli-Streptomyces shuttle plasmid vector [11]
pSE34 E. coli-Streptomyces shuttle plasmid vector This study
pDHS722 pikAI This study
pDHS4111 pikAIII and pikAIV This study
pDHS4149 tylGI This study
pDHS4162 pikAIV This study
pBK3 eryAI This study
pDHS3003 tylGIV-tylGV This study
pDHS3007 tylGV This study
pDHS3016 PikAIV KS6-[AT7-KR7-ACP7-TE]TylGV This study
pDHS3023 PikAIV KS6-AT6-[KR7-ACP7-TE]TylGV This study
pDHS3031 TylGIV KS6-AT6-KR6-[ACP5]PikAIII-PikAIV KS6- AT6-[KR7-ACP7-TE]TylGV This study
bonds in the penultimate tylactone chain elongation in- epi-narbomycin (25). Although we cannot distinguish by
LC/MS and MS/MS the stereochemistry at C-10 of com-termediate would preclude formation of a 14-membered
pounds 22 and 23 and at C-12 of compounds 24 andring macrolactone in S. fradiae. Second, the post-
25, it is likely that the stereochemistry at C-10 of thepolyketide tailoring enzymes in S. venezuelae are flexi-
12-membered ring macrolactone and at C-12 of the 14-ble enough to accept a broad range of hybrid aglycones
membered ring macrolactone was introduced accordingto create biologically active molecules (see below).
to the deduced catalytic specificity of the TylGI KR do-
main. This is evident based on the slight difference be-Complementation of the S. venezuelae pikAI
tween the relative retention times of LC/MS of the pre-Deletion Mutant by tylGI and eryAI
dicted new epi-isomers and those of wild-type products.To expand the applicability of hybrid PKS systems in
The plasmid (pBK3) expressing DEBS1 under control
S. venezuelae and to investigate the behavior of a hybrid
of the ermE* promoter [23] was constructed and intro-
Pik PKS in which the first protein subunit is engineered,
duced into the pikAI-deletion strain. Since the AT do-
we deleted from the S. venezuelae (BB138) chromosome main in module 2 of DEBS1 is specific for methylmalonyl-
the pikAI gene encoding modules L, 1, and 2 (Figure 2D) CoA instead of malonyl-CoA (the extender unit of mod-
and complemented it with the plasmids expressing TylGI ule 2 of the Pik PKS) and DEBS1 module 2 lacks a DH
and DEBS1, respectively (Figure 6). Complementation domain (present in module 2 of Pik PKS [Figure 1]), the
of the pikAI deletion mutant (BB138) by pikAI expressed expected structures of the 12- and 14-membered ring
on a plasmid (pDHS722) restored antibiotic production macrolactones are 8,9-dihydro-8-methyl-9-hydroxy-10-
to wild-type levels (data not shown). deoxymethynolide (26) and 10,11-dihydro-10-methyl-11-
Transformation of BB138 by the plasmid (pDHS4149) hydroxynarbonolide (27), respectively (Figure 6C). In-
expressing TylGI resulted in a strain that produces mac- deed, these two novel aglycones were detected from
rolactones of molecular weight identical to those from the culture extract of the resulting strain (BB138/pBK3)
wild-type S. venezuelae (Figure 6B). The compounds’ and were modified further by DesVII and PikC, leading
MS/MS fragmentation patterns, including the signature to 8,9-dihydro-8-methyl-9-hydroxymethymycin (28),
dehydration pattern as well as the daughter ion of the 8,9-dihydro-8-methyl-9-hydroxyneomethymycin (29),
desosamine moiety, were identical to those obtained 10,11-dihydro-10-methyl-11-hydroxypikromycin (30),
from the antibiotic products of wild-type S. venezuelae. and 10,11-dihydro-10-methyl-11-hydroxy-narbomycin
The predicted structures of the aglycones produced (31) (Figure 6C). LC/MS analysis provided clear evidence
from the resulting hybrid PKS are 10-epi-10-deoxymeth- for the presence of compounds 28, 29, 30, and 31 based
ynolide (20) and 12-epi-narbonolide (21) because TylGI on predicted molecular weights and fragmentation pat-
module 1 catalyzes ketoreduction to give the opposite terns, although the proposed stereochemistry of com-
stereochemistry as compared to that of the correspond- pounds 26–31 remains to be established.
ing module in PikAI (Figure 1). The expected structures
of the macrolides that are modified further from agly- Biological Activity of Hybrid Macrolides
cones 20 and 21 are 10-epi-methymycin (22), 10-epi- An important strength of the S. venezuelae expression
system is the ability to engineer direct in vivo productionneomethymycin (23), 12-epi-pikromycin (24), and 12-
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complete targeted gene and DNA fragments flanking both upstreamof multiple bioactive macrolides from one recombinant
and downstream of the targeted gene. Constructs for gene deletion/strain. Ultimately, this allows the production of novel
replacement were generated with pKC1139 [26], which is a shuttlemacrolides whose biological activity can be assayed by
plasmid for E. coli and Streptomyces, and they were introduced into
TLC separation of the culture extract. As an example, S. venezuelae via protoplast transformation. Spores from individual
the organic solvent extract from the YJ004/pDHS3003 transformants were cultured on nonselective agar plates, and the
cycle was typically repeated up to three times to enhance the proba-recombinant strain displayed multiple zones of growth
bility for recombination. Double crossovers yielding targeted geneinhibition when separated by TLC (Figure 7). The result
replacement with aphII were selected and screened for the kanamy-shows that there are at least two new clearing zones in
cin-resistant, apramycin-sensitive phenotype, and the mutant geno-the extract of the YJ004/pDHS3003 strain compared to
type was confirmed by Southern blot hybridization of genomic DNA.
the pikAIII-IV deletion mutant (YJ004) strain, suggesting The pikAIII-pikAIV-flanking DNA fragments that were used for con-
the existence of multiple bioactive macrolides. The zones structing the pikAIII-pikAIV deletion plasmid (pDHS3004) were PCR
amplified from cosmid-containing pikAII-AV and desVIII-desR genesof target cell growth inhibition in the middle and top of
(pLZ71) [13]; the following nucleotides with engineered restrictionthe TLC plate are due to methymycin/neomethymycin
sites (in italics) were used for cloning: a HindIII-XbaI fragment con-and the hybrid 14-membered ring macrolides (15, 16),
taining the 3-region of pikAII, forward 5-AAAAAGCCTCGAGGACGrespectively. The culture extracts of HK954/pDHS3007,
GGGTGCTCCGGCACCT-3 and reverse AAATCTAGAGGTGCCGG
HK954/pDHS3023, and YJ004/pDHS3031 strains dis- TGGTGTCGGGCAGGTC-3; and a KpnI-EcoRI fragment containing
played very similar zones of growth inhibition (data not pikAV and part of desVIII, forward 5-AAAGGTACCGAGGGGGCGG
GCAAGTGACCGACAGA-3 and reverse 5-AAAGAATTCGGACAGshown).
CGGCCGGAGCCGCTCCA-3. The pikAIV-flanking DNA fragments
that were used for the pikAIV deletion plasmid (pDHS954) were PCRSignificance
amplified from the same cosmid pLZ71 by the use of the following
nucleotides: a HindIII-XbaI fragment containing the 3-region of
The hybrid PikA, TylG, and DEBS modular PKS systems pikAIII, forward 5-AAAAAGCCTGTGGTCCGTCACCCAGGGCGC
engineered at the beginning or end of the Pik PKS com- GGT-3 and reverse 5-AAAGAATTCGTGGGGCAGGACCGCGGTCG
GGTC-3; and a fragment containing pikAV and part of desVIII asplex in S. venezuelae resulted in the production of multi-
described above.ple macrolides that differ in size of the macrolactone
The pikAI-flanking DNA fragments that were used for constructingcore and are modified diversely at multiple positions by
the pikAI deletion plasmid (pDHS4138) were PCR amplified fromglycosylation and hydroxylation. Taken together, these
cosmid pLZ51 [13]; the following primers with engineered restriction
results demonstrate the unique advantages of the S. sites (in italics) were used for cloning: a HindIII-XbaI fragment con-
venezuelae system for combinatorial biosynthetic cre- taining the promoter region of pikAI, forward 5-AAAAAGCTTGGGGAT
GTGGCGCCGGAGGATC-3 and reverse 5-TTTTCTAGACATCCGation of natural-product structural diversity. A continu-
GCTCCGTCTCCGGAAGCC-3; and a KpnI-EcoRI fragment con-ing challenge of this approach is the relatively low
taining the 5-end of pikAII, forward 5-AAAGGTACCCCGTCCCGGproductivity of these hybrid systems. However, an un-
GCACCTCGACTC-3 and reverse 5-TTTGAATTCGCCGACACCAGderstanding of the regulation of the Pik biosynthetic
CCACGGCACC-3. The strains used in this study are summarized
pathway has already provided a strategy for improving in Table 1.
the level of production of hybrid macrolide com-
pounds. Current efforts are focused on enhancing the Construction of Plasmids for Hybrid PKS Expression
metabolic efficiency of these hybrid systems in the S. All the expression plasmids were derivatives of pDHS618, pDHS702
[11], and pSE34 (derived from pWHM3 [27]), which are shuttle vec-venezuelae host strain.
tors with an E. coli colE origin of replication and either a low-copy
Streptomyces SCP2* origin [28] or a high-copy pIJ101 origin [28].Experimental Procedures
Plasmids were maintained in S. venezuelae by using the appropriate
antibiotic at a concentration of 25–50 mg/liter. The expression ofBacterial Strains and Culture Conditions
S. venezuelae ATCC 15439 was used for the construction of Pik genes cloned in plasmids pDHS618 and pDHS702 is driven by the
pikAI promoter, whereas gene expression in pSE34 derivatives isPKS deletion mutants. S. venezuelae transformants were selected
on R2YE agar plates [23] by overlaying with 1 ml of an appropriate dependent on the ermE* promoter.
The tylGI gene was subcloned from pSET506 (a gift from Eli Lillyantibiotic, apramycin (0.5 mg/ml), kanamycin (1 mg/ml), or thiostrep-
ton (0.5 mg/ml). SGGP liquid medium [24] was used for propagation Co., GenBank accession number SFU78289) as a MunI-NsiI frag-
ment into pDHS702 through a series of PCR and subcloning stepsof S. venezuelae. S. venezuelae containing plasmids were grown on
solid SPA medium (1 g of yeast extract; 1 g of beef extract; 2 g of and designated pDHS4149.
The eryAI gene was placed into pSE34 as an XbaI-HindIII fragmenttryptose; 10 g of glucose; trace amount of ferrous sulfate; 15 g of
agar/liter) with an appropriate antibiotic or combination of antibiot- through a series of PCR and subcloning steps, yielding plasmid pBK3.
The tylGV gene was first subcloned from pOJ463 and pOJ566 (aics (25 mg/liter of apramycin; 50 mg/liter of kanamycin; 25 mg/
liter of thiostrepton) for the production and analysis of polyketides. gift from Eli Lilly Co.) as an EcoRI-XbaI fragment into LITMUS28
(pDHS3006) through a series of PCR and subcloning steps andEscherichia coli DH5 was used as a host for DNA manipulation.
placed into the expression vector pDHS618, yielding plasmid
pDHS3007.Manipulation of DNA and Organisms
The routine manipulation of DNA in E. coli was performed with standard Plasmid pDHS3012 is a pDHS3006 derivative in which a HindIII
site has been engineered immediately downstream of the KS domainprocedures in LITMUS28 (New England Biolabs). The polymerase chain
reaction (PCR) was performed with Pfu Turbo polymerase (Stratagene) in TylGV (by mutating the sequence CCGGCCCCGGCGGACCGGGG
TGTCCGCCTT into CCGGCCCCGGCGGACCGGGGTGTCAAGCTT)under the recommended conditions. S. venezuelae transformation was
performed by the standard protoplast procedure [23]. and the introduced restriction site results in the alteration of a single
amino acid residue. This fusion junction was engineered by standard
PCR mutagenesis procedures.Construction of Deletion Mutants
A replicative plasmid-mediated homologous recombination ap- Plasmid pDHS3015 was constructed by replacement of the KS
domain of TylGV in pDHS3012 with the KS domain of PikAIV asproach was developed previously to conduct gene deletion/replace-
ment in S. venezuelae [13]. Plasmids for gene deletion were con- an EcoRI-HindIII fragment, which was PCR amplified from cosmid
pLZ71 by the use of the following oligonucleotide (cloning sites instructed with a kanamycin resistance gene (aphII) [25] replacing the
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italics): forward 5-AAAGAATTCTGACCCGACCGCGGTCCTGCC Biological Activity Assays
The biological activity of extracts prepared as above was assayedCCA-3 and reverse 5-AAAAAGCTTGAGACGCCCGCCCGGCGGAG
against Bacillus subtilis by overlaying a TLC plate that had beenCCGG-3. The resulting hybrid PKS gene was placed into pDHS618
developed with each extract with soft agar containing freshly grownas an EcoRI-XbaI fragment, generating the expression plasmid
B. subtilis. The solvent system for TLC was chloroform:metha-pDHS3016.
nol:25% ammonium hydroxide (90:10:1). The TLC plate spotted withPlasmid pDHS3020 is a pDHS3006 derivative in which a PstI site
5–10 l of each of the extracts was developed, dried, placed on ahas been engineered immediately downstream of the AT domain in
water agar plate and overlaid with soft agar containing 50 l ofTylGV (by mutation of the sequence GCCTCCCGGCACCGCCGCTA
culture of B. subtilis grown overnight. After overnight incubation atCTCCCTCGCC into GCCTCCCGGCACCGCCGCTACTCCCTGCAG)
37C, the TLC plate was stained with Coomassie blue solution andand the introduced restriction site results in the alteration of a single
washed with water for visualization of zones of target cell growthamino acid residue. This fusion junction was engineered by standard
inhibition.PCR mutagenesis procedures.
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